Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (281-290 of 329) with videos related to

Pageof 33
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2021
First-Line Afatinib plus Cetuximab for <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung StudyAlexis B Cortot, Anne Madroszyk, Etienne Giroux-Leprieur, et al.
The Lancet. Infectious Diseases|December 1, 2024
Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysisAbhinav Sengupta, Animesh Ray, Ashish Datt Upadhyay, et al.
The European Respiratory Journal|August 5, 2017
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater ParisBoris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohortSimon Baldacci, Benjamin Besse, Virginie Avrillon, et al.
Thorax|August 12, 2017
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosisLucile Sesé, Hilario Nunes, Vincent Cottin, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
Autoimmunity Reviews|September 28, 2016
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
Pageof 33

Showing results (281-290 of 329) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2021
First-Line Afatinib plus Cetuximab for <i>EGFR</i>-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung StudyAlexis B Cortot, Anne Madroszyk, Etienne Giroux-Leprieur, et al.
The Lancet. Infectious Diseases|December 1, 2024
Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysisAbhinav Sengupta, Animesh Ray, Ashish Datt Upadhyay, et al.
The European Respiratory Journal|August 5, 2017
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater ParisBoris Duchemann, Isabella Annesi-Maesano, Camille Jacobe de Naurois, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohortSimon Baldacci, Benjamin Besse, Virginie Avrillon, et al.
Thorax|August 12, 2017
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosisLucile Sesé, Hilario Nunes, Vincent Cottin, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
Autoimmunity Reviews|September 28, 2016
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Vincent Cottin, Elisabeth Bel, Paolo Bottero, et al.
The European Respiratory Journal|December 8, 2018
Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypesRaphael Borie, Diane Bouvry, Vincent Cottin, et al.
Pageof 33